Elderly woman eating breakfast and talking with a younger relative.

Psychosis occurs when a person's perceptions do not match reality, causing them to experience distressing symptoms that can significantly impact their daily functioning. People experiencing psychosis may have hallucinations (seeing or hearing things that aren't there), delusions (fixed false beliefs), disorganized thinking, or difficulty distinguishing what is real from what is not. As a symptom that can indicate serious underlying medical or mental health conditions, prompt diagnosis and appropriate treatment are essential for recovery.

Modern treatment for psychosis has evolved significantly, with research demonstrating that early intervention and comprehensive care approaches lead to better outcomes. Treatment typically combines multiple evidence-based strategies tailored to each individual's needs and circumstances.

Table of Contents

  • Understanding Psychosis and Its Treatment
  • Inpatient Treatment for Psychosis
  • Medication for Psychosis
  • Therapy for Psychosis
  • Family Interventions
  • Coordinated Specialty Care
  • Brain Stimulation Therapies
  • Treatment for Medical Causes of Psychosis
  • Frequently Asked Questions
  • How Therapy Can Help / Find a Therapist

Understanding Psychosis and Its Treatment

Psychosis affects approximately 1.5 to 3.5% of people during their lifetime, though many more may experience at least one psychotic symptom. The current thinking is that although around 1.5 to 3.5% of people will meet diagnostic criteria for a psychotic disorder, a significantly larger, variable number will experience at least one psychotic symptom in their lifetime. It often emerges in late adolescence or early adulthood, making early recognition and intervention crucial for long-term recovery.

Recent advances in treatment have transformed the outlook for people experiencing psychosis. The Recovery After an Initial Schizophrenia Episode research initiative, launched by NIMH to test the effectiveness of coordinated specialty care to treat first-episode psychosis, has transformed the mental health landscape in the United States, helping thousands of individuals achieve better outcomes through comprehensive, recovery-oriented care.

Inpatient Treatment for Psychosis

When psychosis causes severe disruption to a person's thinking and behavior, inpatient treatment may be necessary to ensure safety and stabilize symptoms. This temporary but intensive level of care provides round-the-clock support in a psychiatric hospital or specialized treatment facility.

During hospitalization, individuals receive:

  • Comprehensive psychiatric evaluation and diagnosis
  • Medication management with close monitoring for effectiveness and side effects
  • Individual and group therapy sessions
  • Behavioral interventions to manage acute symptoms
  • Development of a personalized treatment plan
  • Coordination with outpatient providers for continuity of care
  • Family education and involvement when appropriate

Some specialized residential treatment facilities offer longer-term programs that go beyond acute stabilization. These programs teach essential life skills, stress management techniques, conflict resolution strategies, and other tools for managing psychosis in daily life. The goal is to help individuals develop the skills and confidence needed to live independently while managing their symptoms effectively.

Medication for Psychosis

Antipsychotic medications remain a cornerstone of psychosis treatment, with research showing their effectiveness in reducing symptoms and preventing relapse. Clozapine is considered the standard treatment for this subgroup, but the evidence is not unequivocal. There are several potential alternatives being used because of the possible adverse effects of clozapine.

Types of Antipsychotic Medications

Modern treatment options include:

  • Second-generation antipsychotics (also called atypical antipsychotics) such as olanzapine, risperidone, aripiprazole, quetiapine, and ziprasidone
  • First-generation antipsychotics (typical antipsychotics) like haloperidol
  • Third-generation antipsychotics including newer medications with different mechanisms of action
  • Long-acting injectable formulations for individuals who have difficulty with daily medication adherence

Recent network meta-analyses have shown that LAI antipsychotics perform slightly better in the real world than according to RCTs. Otherwise, RCT evidence was in line with real-world evidence for most between-drug comparisons, but RCTs might overestimate effectiveness of antipsychotics observed in routine care settings.

Medication Effectiveness and Selection

Research indicates that olanzapine, risperidone, and aripiprazole presented advantages for the first-line treatment of first episode of psychosis in terms of effectiveness, with individual response varying based on factors such as:

  • Symptom profile and severity
  • Previous treatment response
  • Side effect tolerance
  • Individual preferences
  • Medical conditions

Additional Medications

Treatment may also include:

  • Antidepressants for co-occurring depression
  • Anti-anxiety medications for managing anxiety symptoms
  • Mood stabilizers for mood symptoms
  • Anti-seizure medications in specific cases

It's important to note that while medications effectively manage symptoms, they work best as part of a comprehensive treatment approach that includes psychosocial interventions.

Therapy for Psychosis

Psychotherapy plays a vital role in psychosis treatment, often working synergistically with medication to improve outcomes. We found evidence that psychological interventions (this component grouped all psychological treatment intended to treat, or ameliorate the consequences of, psychotic symptoms) are beneficial for reducing negative symptoms (iSMD -0.24, 95% CI -0.44 to -0.05, p = 0.014) at 3-month follow-up and may be associated with clinically relevant benefits in improving social functioning scores at 1-year follow-up (iSMD -0.52, 95% CI -1.05 to 0.01, p = 0.052). The addition of case management has a beneficial effect on reducing negative symptoms (iSMD -1.17, 95% CI -2.24 to -0.11, p = 0.030) and positive symptoms (iSMD -1.05, 95% CI -2.02 to -0.08, p = 0.033) at 1-year follow-up.

Cognitive Behavioral Therapy for Psychosis (CBTp)

CBTp is specifically adapted for individuals experiencing psychosis and focuses on:

  • Understanding and coping with psychotic experiences
  • Challenging distressing beliefs and thought patterns
  • Developing reality-testing skills
  • Managing stress and preventing relapse
  • Building self-esteem and confidence
  • Improving social functioning

Our findings from the 33 meta-analyses support the efficacy of cognitive and behavioral interventions in reducing total symptoms (Median g = −0.38; Range g = −1.56 to −0.08).

Metacognitive Training (MCT)

Metacognitive training for psychosis (MCT) targets cognitive biases implicated in the pathogenesis of psychosis, e.g., jumping to conclusions, overconfidence in errors, and inflexibility. This systematic meta-review investigated the current meta-analytic evidence for the effectiveness of MCT with respect to core symptom features in schizophrenia (i.e., positive symptoms, delusions and hallucinations, negative symptoms, and overall psychotic symptoms).

Individual and Group Therapy

Therapy can be delivered in various formats:

  • Individual therapy provides personalized support for processing experiences, developing coping strategies, and working toward personal goals
  • Group therapy offers peer support and shared learning opportunities
  • Skills training groups focus on specific areas like social skills, problem-solving, or daily living skills

Psychosocial Rehabilitation

Comprehensive psychosocial interventions help individuals:

  • Rebuild social connections
  • Return to work or education
  • Develop independent living skills
  • Manage symptoms in daily life
  • Improve overall quality of life

Family Interventions

Family interventions have emerged as a critical component of effective psychosis treatment. Family interventions for psychosis (FIp) are effective in reducing service user relapse and carer distress in people with schizophrenia-spectrum conditions. Several treatment and best practice guidelines recommend FIp for all people with schizophrenia... The findings indicate that FIp is an effective intervention for early psychosis service users and their relatives.

Benefits of Family Involvement

Research demonstrates that family interventions improve service user functioning and reduce the likelihood of relapse by the end of treatment. Carers receiving FIp were more likely to shift from high to low expressed emotion and less likely to report patient-focused criticism or engage in conflict communication than carers randomized to standard care. These interventions reduce carer burden, improve carer well-being and lead to improvements in criticism, improve patient functioning and psychotic symptoms, and reduce the likelihood of relapse.

Components of Family Interventions

Effective family programs typically include:

  • Psychoeducation about psychosis and its treatment
  • Communication skills training to improve family interactions
  • Problem-solving strategies for managing challenges
  • Stress management techniques for family members
  • Crisis planning and relapse prevention
  • Emotional support for processing the impact of psychosis

Delivery Methods

Family interventions can be delivered through:

  • Multi-family groups that allow families to learn from each other
  • Individual family sessions tailored to specific needs
  • Digital platforms and telehealth options for improved accessibility
  • Combination approaches that blend different formats

Coordinated Specialty Care

Coordinated Specialty Care (CSC) represents a breakthrough in psychosis treatment, particularly for individuals experiencing their first episode. NIMH took note of what other countries were doing to effectively treat psychosis and combined them into a package of services that, in the United States, became known as coordinated specialty care (CSC)... Emphasis is on easy access to care and shared decision-making among a team of specialists who work with the patient and their family to create an individualized treatment plan reflecting their unique needs. Success is measured not only in reducing psychosis symptoms through psychotherapy and medication but in enhancing family support and teaching life skills to promote overall recovery and participation in work or school.

Key Components of CSC

CSC programs integrate multiple evidence-based interventions:

  • Team-based care with psychiatrists, therapists, case managers, and peer specialists
  • Shared decision-making between the treatment team, individual, and family
  • Low patient-to-staff ratios for personalized attention
  • Rapid access to care to minimize treatment delays
  • Recovery-focused approach emphasizing functional goals
  • Supported employment and education services

Effectiveness of CSC

The implementation of CSC has shown remarkable results. Baseline findings from the RAISE studies documented areas in need of improvement, including the long duration of untreated psychosis, variable adherence to treatment guidelines, and poor attention to comorbid medical conditions associated with premature mortality. In addition, the RAISE studies demonstrated that early intervention improves clinical outcomes among youth and young adults with first episode psychosis, and that CSC is a feasible and cost-effective approach to early intervention in first episode psychosis. Through collaborations with other federal agencies, NIMH transformed these findings into real-world change. CSC is now the standard of care for early psychosis, with more than 360 CSC programs across the country.

Brain Stimulation Therapies

Electroconvulsive Therapy (ECT)

For individuals with severe psychotic symptoms that haven't responded to other treatments, electroconvulsive therapy (ECT) can be highly effective. ECT has been shown to have an overall response rate of 82%–90% for treating psychotic depression, which is superior to combination pharmacologic therapy.

Modern ECT is performed under general anesthesia with muscle relaxants, making it much safer than historical procedures. Benefits include:

  • Rapid symptom improvement, often within days or weeks
  • High effectiveness for psychotic depression
  • Usefulness in treatment-resistant cases
  • Safety for pregnant individuals and elderly patients

Recent studies show an overall ECT response rate of 70.46%. Positive predictors of treatment response included first-episode schizophrenia, higher baseline positive symptom scores, and longer EEG seizure duration.

Other Brain Stimulation Approaches

Emerging treatments being studied include:

  • Repetitive transcranial magnetic stimulation (rTMS)
  • Magnetic seizure therapy (MST)
  • Other novel neurostimulation techniques

Treatment for Medical Causes of Psychosis

When psychosis results from an underlying medical condition, treatment must address the root cause:

Medical Conditions That Can Cause Psychosis

  • Infections affecting the brain, requiring antibiotic or antiviral treatment
  • Autoimmune disorders needing immunosuppressive therapy
  • Metabolic disturbances requiring correction of imbalances
  • Neurological conditions such as epilepsy or brain tumors
  • Substance-induced psychosis requiring detoxification and addiction treatment

Diagnostic Approach

Healthcare providers must carefully differentiate between:

  • Primary psychotic disorders (like schizophrenia)
  • Psychosis secondary to medical conditions
  • Substance-induced psychotic symptoms
  • Delirium that may mimic psychosis

Accurate diagnosis ensures appropriate treatment targeting the underlying cause while managing psychotic symptoms.

Frequently Asked Questions

How long does psychosis treatment typically take?

Treatment duration varies considerably based on individual factors. Acute symptoms often improve within weeks to months with appropriate treatment. However, many people benefit from ongoing treatment to maintain wellness and prevent relapse. Launched in 2019, EPINET is a learning health care system for early psychosis, aimed at enhancing coordinated specialty care to improve early identification, diagnosis, clinical assessment, intervention effectiveness, service delivery, and health outcomes. EPINET now has 8 regional scientific hubs and has enrolled approximately 4,000 participants from more than 100 clinics across 17 states. To foster knowledge sharing and promote accessible early psychosis care resources, the EPINET National Data Coordinating Center launched a web portal, making the EPINET Core Assessment Battery available to all early psychosis care clinicians to assess key domains of early psychosis, recovery, and treatment.

What if medications don't work or cause intolerable side effects?

If initial medications aren't effective, psychiatrists can:

  • Adjust dosages to optimize benefits while minimizing side effects
  • Switch to different antipsychotic medications with varied mechanisms
  • Add augmenting medications to enhance effectiveness
  • Consider clozapine for treatment-resistant cases
  • Explore brain stimulation therapies like ECT
  • Intensify psychosocial interventions

Can people with psychosis live normal lives?

Yes, many people with psychosis lead fulfilling, productive lives. With appropriate treatment and support, individuals can:

  • Return to work or school
  • Maintain meaningful relationships
  • Live independently
  • Pursue personal goals and interests
  • Contribute to their communities

Recovery is a personal journey that looks different for everyone, but hope and possibility exist for all.

Is psychosis treatment safe during pregnancy?

Treatment decisions during pregnancy require careful consideration of risks and benefits. Some approaches that may be considered include:

  • Certain antipsychotic medications with established safety profiles
  • ECT, which can be safely administered during pregnancy
  • Intensive psychotherapy and support services
  • Close monitoring by both psychiatric and obstetric teams

Healthcare providers work closely with pregnant individuals to develop safe, effective treatment plans.

How can I support a loved one in psychosis treatment?

Family and friends play crucial roles in recovery:

  • Learn about psychosis and its treatment
  • Participate in family therapy or support groups
  • Maintain open, non-judgmental communication
  • Help with treatment adherence when needed
  • Encourage healthy lifestyle choices
  • Celebrate progress and small victories
  • Take care of your own mental health

What role does lifestyle play in psychosis treatment?

Healthy lifestyle choices complement formal treatment:

  • Regular sleep schedules support brain health
  • Exercise improves mood and reduces stress
  • Nutritious diet supports overall wellness
  • Avoiding drugs and limiting alcohol prevents symptom exacerbation
  • Stress management techniques enhance coping
  • Social connections provide essential support

How Therapy Can Help / Find a Therapist

Finding the right mental health professional is an essential step in psychosis treatment and recovery. A skilled therapist experienced in working with psychosis can provide invaluable support throughout your journey.

What to Look for in a Therapist

When seeking treatment for psychosis, consider therapists who:

  • Have specialized training in psychotic disorders
  • Offer evidence-based treatments like CBTp or family therapy
  • Work collaboratively with psychiatrists and other providers
  • Take a recovery-oriented, strengths-based approach
  • Respect your experiences and treatment preferences
  • Have experience with early intervention programs

The GoodTherapy Directory

The GoodTherapy directory can help you find qualified mental health professionals in your area who specialize in psychosis treatment. You can search by:

  • Location
  • Specialties and treatment approaches
  • Insurance acceptance
  • Languages spoken
  • Telehealth availability

Remember that finding the right therapist may take time. It's okay to meet with several providers before choosing one who feels like the best fit for your needs.

Taking the First Step

If you or a loved one is experiencing symptoms of psychosis, don't wait to seek help. Early intervention leads to better outcomes, and effective treatments are available. Whether you're looking for initial evaluation, ongoing therapy, or specialized programs like coordinated specialty care, qualified professionals are ready to help.

Find a Therapist Near You

References:

  1. Berendsen, S., Berendse, S., van der Torren, J., Vermeulen, J., & de Haan, L. (2024). Cognitive behavioural therapy for the treatment of schizophrenia spectrum disorders: An umbrella review of meta-analyses of randomised controlled trials. eClinicalMedicine, 67, 102392. https://doi.org/10.1016/j.eclinm.2023.102392
  2. Calabrese, J., & Al Khalili, Y. (2023). Psychosis. In StatPearls. StatPearls Publishing. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK546579/
  3. Crespo-Facorro, B., de la Foz, V. O. G., Mata, I., Ayesa-Arriola, R., Suarez-Pinilla, P., Valdizan, E. M., Martinez-Garcia, O., & Pérez-Iglesias, R. (2020). Antipsychotic treatment effectiveness in first episode of psychosis: PAFIP 3-year follow-up randomized clinical trials comparing haloperidol, olanzapine, risperidone, aripiprazole, quetiapine, and ziprasidone. International Journal of Neuropsychopharmacology, 23(4), 217-229. https://doi.org/10.1093/ijnp/pyaa004
  4. Dong, S., Schneider-Thoma, J., Bighelli, I., Siafis, S., Wang, D., Burschinski, A., Schestag, K., Samara, M., & Leucht, S. (2024). A network meta-analysis of efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 274, 917–928. https://doi.org/10.1007/s00406-023-01654-2
  5. Fusar-Poli, P., Davies, C., Solmi, M., Brondino, N., De Micheli, A., Kotlicka-Antczak, M., Shin, J. I., & Radua, J. (2025). Preventing psychosis in people at clinical high risk: An updated meta-analysis by the World Psychiatric Association Preventive Psychiatry section. Molecular Psychiatry. https://doi.org/10.1038/s41380-025-02902-8
  6. Gleeson, J. F. M., Ludwig, K., Stiles, B. J., Piantella, S., McNab, C., Cotton, S., Fraser, M. I., Alvarez-Jimenez, M., Watson, A., Fraser, E., & Penn, D. L. (2025). Systematic review and meta-analysis of family-based interventions for early psychosis: Carer and patient outcomes. Schizophrenia Research, 273, 57-69. https://doi.org/10.1016/j.schres.2025.01.006
  7. Jin, X., Zhang, Y., Wang, L., & Li, H. (2025). Metacognitive training for psychosis (MCT): A systematic meta-review of its effectiveness. Translational Psychiatry, 15, Article 344. https://doi.org/10.1038/s41398-025-03344-0
  8. Kane, J. M., Robinson, D. G., Schooler, N. R., Mueser, K. T., Penn, D. L., Rosenheck, R. A., Addington, J., Brunette, M. F., Correll, C. U., Estroff, S. E., Marcy, P., Robinson, J., Meyer-Kalos, P. S., Gottlieb, J. D., Glynn, S. M., Lynde, D. W., Gingerich, S., Christensen, T. N., Melton, R. K.,... Heinssen, R. K. (2016). Comprehensive versus usual community care for first-episode psychosis: 2-year outcomes from the NIMH RAISE early treatment program. American Journal of Psychiatry, 173(4), 362-372. https://doi.org/10.1176/appi.ajp.2015.15050632
  9. Kelkar, R., Liu, G. C., Goodman, M. S., Peterchev, A. V., Lisanby, S. H., & Moeller, J. R. (2025). Clinical effectiveness of electroconvulsive therapy for psychotic vs nonpsychotic depression: A cohort study. Journal of Clinical Psychiatry, 86(1), 24m15399. https://doi.org/10.4088/JCP.24m15399
  10. Kritzer, M. D., Peterchev, A. V., & Camprodon, J. A. (2023). Electroconvulsive therapy: Mechanisms of action, clinical considerations, and future directions. Harvard Review of Psychiatry, 31(3), 101-113. https://doi.org/10.1097/HRP.0000000000000365
  11. Ma, C., Chien, W. T., & Bressington, D. T. (2018). Family intervention for caregivers of people with recent-onset psychosis: A systematic review and meta-analysis. Early Intervention in Psychiatry, 12(4), 535-560. https://doi.org/10.1111/eip.12494
  12. Mukhtar, F., Regenold, W., & Lisanby, S. H. (2023). Recent advances in electroconvulsive therapy in clinical practice and research. F1000Research, 12, 13. https://doi.org/10.12703/r/12-13
  13. National Institute of Mental Health. (2024). From breakthroughs to best practices: How NIMH transforms research into real-world care. Retrieved from https://www.nimh.nih.gov/about/director/messages/2024/from-breakthroughs-to-best-practices-how-nimh-transforms-research-into-real-world-care
  14. National Institute of Mental Health. (2024). Schizophrenia: Overview and treatment. Retrieved from https://www.nimh.nih.gov/health/topics/schizophrenia
  15. National Institute of Mental Health. (2024). Strategic planning reports: Challenges and opportunities. Retrieved from https://www.nimh.nih.gov/about/strategic-planning-reports/challenges-and-opportunities
  16. National Institute of Mental Health. (2023). RAISE-ing the standard of care for schizophrenia: The rapid adoption of coordinated specialty care in the United States. Retrieved from https://www.nimh.nih.gov/news/science-updates/2023/raise-ing-the-standard-of-care-for-schizophrenia-the-rapid-adoption-of-coordinated-specialty-care-in-the-united-states
  17. National Institute of Mental Health. (2025). NIMH FY 2025 Budget Fact Sheet. Retrieved from https://www.nimh.nih.gov/about/budget/nimh-fy-2025-budget-fact-sheet
  18. Petracca, M., Mula, M., Barbuti, M., Martino, I., & Falaschi, V. (2023). The NIMH research portfolio: An update. Primary Care Companion for CNS Disorders, 25(4), 23m03486. https://doi.org/10.4088/PCC.23m03486
  19. Salles, J., Birmes, P., Yrondi, A., Schmitt, L., & Sarramon, C. (2021). Electroconvulsive therapy as a potential first-choice treatment in treatment-resistant depression: A systematic review. International Review of Psychiatry, 33(4), 382-395. https://doi.org/10.1080/09540261.2021.1891517
  20. Sampogna, G., Di Vincenzo, M., Giuliani, L., Menculini, G., Mancuso, E., Arsenio, E., Cipolla, S., Della Rocca, B., Martiadis, V., Signorelli, M. S., & Fiorillo, A. (2023). A systematic review on the effectiveness of antipsychotic drugs on the quality of life of patients with schizophrenia. Brain Sciences, 13(11), 1577. https://doi.org/10.3390/brainsci13111577
  21. Solmi, M., Taipale, H., Holm, M., Tiihonen, J., Tanskanen, A., Mittendorfer-Rutz, E., Suvisaari, J., Torniainen, M., Kärkkäinen, S., Brunoni, A. R., Carvalho, A. F., & Correll, C. U. (2024). Efficacy and effectiveness of antipsychotics in schizophrenia: Network meta-analyses combining evidence from randomised controlled trials and real-world data. The Lancet Psychiatry, 11(1), 52-64. https://doi.org/10.1016/S2215-0366(23)00366-8
  22. Stoleru, S. G., Fischer, B., & Kurtz, M. M. (2025). Cognitive behavioral therapy for psychosis (CBTp): A meta-analytic review of effectiveness across diagnoses and treatment settings. Schizophrenia Research, 275, 14-25. https://doi.org/10.1016/j.schres.2024.12.002
  23. Swanson, M. (2024). Effectiveness of cognitive and behavioral interventions in the treatment of schizophrenia: An umbrella review of meta-analyses. Journal of Clinical Medicine, 15(1), 187. https://doi.org/10.3390/jcm15010187
  24. Williams, R., Ostinelli, E. G., Agorinya, J., Minichino, A., De Crescenzo, F., Maughan, D., Puntis, S., Cliffe, C., Kurtulmus, A., Lennox, B. R., & Cipriani, A. (2024). Comparing interventions for early psychosis: A systematic review and component network meta-analysis. eClinicalMedicine, 70, 102537. https://doi.org/10.1016/j.eclinm.2024.102537
  25. World Federation of Societies of Biological Psychiatry. (2024). INTEGRATE: International guidelines for the algorithmic treatment of psychotic disorders. Retrieved from https://www.wfsbp.org/wp-content/uploads/2025/11/INTEGRATE_International-guidelines-for-the-algorithmic.pdf